Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...Russia’s healthcare watchdog has said that it has not detected any cases of blood clots arising from the use of the country’s Sputnik V vaccine....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Johanna Seibt of Aarhus University in Denmark, co-founder of the foundation, says social robots are more than tools — “they change how we are as human beings”, while Noel Sharkey, robotics professor at Sheffield...
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...When Lola Lely wanted to create original cutlery for a Royal College of Art project last year, she couldn’t find a cutlery maker in Sheffield – the home of British steel – to take it on....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...A Sheffield company has launched a “virtual rat” computer programme, which it claims will mimic drug trials on animals....
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...Bayer, Novo Nordisk, Johnson & Johnson, Pfizer and Roche are in the top 10; each has filed between 30 and 40 families of stem cell patents since 2000....
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
International Edition